1-stearoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoserine

Metabolite details

Identifier

UZBGQAUYCOMBMI-FBAMSMPZSA-N

InChI Key

UZBGQAUYCOMBMI-FBAMSMPZSA-N

IUPAC name

O-{[(2R)-2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-3-(octadecanoyloxy)propoxy](hydroxy)phosphoryl}-L-serine

Preferred name

1-stearoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoserine

INN name

—

Synonym

1-octadecanoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoserine

ChEBI

CHEBI:84506

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)

Observed in differential profiles

• WT_vs_WT_Aco
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• 4_weeks_vs_52_weeks
• G1_Ctrl_vs_G2_Ab
• G1_Ctrl_vs_G2_Ab